African Journal of Oral Health Advertisement
  Home arrow Current Issue arrow Article 7 Volume 1 - Pattern of oral cancers ..
Main Menu
Home
Membership of IADR
Current Issue
Subscription/Reprints
Editorial Board
Submitting Articles
Our Mission
The Web Links
Contact Us
About Us
Download
Advert in AJOH
News
Member Login
Username

Password

Remember me
Forgotten your password?
No account yet? Create one
Archive
Sections
Who's Online
We have 7 guests online
 Wednesday, 07 January 2009
Article 7 Volume 1 - Pattern of oral cancers .. | Print |  E-mail

Histological Types

Carcinomas constituted 81.5% of oral cancers in this series. (Table 2).

Age and Gender Distribution

Table 3 shows the gender and age distribution for all sites. Cancers of the palate and floor of the mouth showed the least age of occurrence (mean= 33.8 ± 19.6 years), with cancers of other sites occurring in the 5th and 6th decades of life. 92.6% of oral cancers were reported in patients aged 15 years and above, while only 5.6% were reported in patients aged 0 to 14 years (p<0.005).

HIV Status and AIDS-related Cancers

AIDS-related cancers (ARCs) identified in Africa are kaposi sarcoma and non-hodgkin’s lymphoma2.

Table 2. Age distribution of the histological types of oral cancers

Histological Types

Age Groups (Years) and Gender

TOTAL

0-14

15-75+

Unspecified

M

F

M

F

M

F

Carcinomas

2

0

30

11

0

1

44

Sarcomas

0

1

5

3

0

0

9

Lymphomas

0

0

1

0

0

0

1

TOTAL

2

1

36

14

0

1

54

X2=0.040, df=1, p=0.842 (The category "Unspecified" was not included in the analysis and all histological types were merged due to the small numbers in these categories).

Table 3. Mean ages of occurence of cancers

Site

Mean Age of Occurrence (Years)

Males

Females

All Gender

Tongue

56.1 ± 17.5

48.4 ± 17.9

53.9 ± 17.5

Palate

38.3 ± 19.5

23.5 ± 17.9

33.8 ± 19.6

Lip

44.8 ± 26.5

38 ± 2.8

43.1 ± 22.7

Gingiva

47.5 ± 10.6

------

47.5 ± 10.6

Buccal Mucosa

------

52 ± 0.0

52 ± 0.0

Floor of Mouth

38.3 ± 19.5

23.5 ± 17.9

33.8 ± 19.6

Unspecified Mouth

54 ± 22.6

50.5 ± 0.7

52.3 ± 13.2

Kaposi Sarcoma

55 ± 0.0

29.5 ± 0.7

38 ± 14.7

Four AIDS-related cancers, Kaposi sarcoma (75%) and non-hogkin’s lymphoma (25%) were reported. These constitute 7.4% of oral cancers and a yearly rate of 0.46%. Kaposi sarcoma was reported in the 4th decade of life, with a mean age of occurrence of 38 ± 14.7 years (males=55 ± SD years; females = 29.5 ± 0.7 years).

Duration of Symptoms

Cancers of the tongue were reported earliest, in comparison with patients with lip cancers who waited longest before reporting for treatment (Table 4).

Table 4. Duration of symptoms for different intra-oral sites and cancer-types.

Sites (n)

Duration of Symptoms (Months)

Tongue (4)

13 ± 13.3

Palate (5)

13.4 ± 10.5

Lip (3)

23.0 ± 22.9

Gingiva (1)

0.5 ± 0.0

Buccal Mucosa (1)

0.1 ± 0.0

   

Types (n)

 

Carcinoma (12)

15.7 ± 14.9

Squamous Cell Carcinoma (8)

16.8 ± 16.7

Salivary Gland Carcinoma (2)

24.0 ± 0.0

Sarcoma (3)

4.4 ± 6.6

Kaposi Sarcoma (2)

6.3 ± 8.1

Patients diagnosed with sarcomas presented earlier than carcinoma patients, while cases of Squamous cell carcinoma stayed longest before presentation to the hospital.

Table 5. Treatment Modalities for Different Oral Cancers (n=17)

Type of Therapy (%)

Treatment

Number (%)

Monotherapy

(23.5)

Primary Surgery

1 (5.9)

Primary Radiotherapy

2 (11.7)

Primary Chemotherapy

1 (5.9)

Combination Therapy

(5.9%)

Surgery + radiotherapy

1 (5.9)

Surgery + Chemotherapy

0 (0.0)

Radiotherapy +Chemotherapy

0 (0.0)

Surgery + Radiotherapy + Chemotherapy

0 (0.0)

None (70.6)

No Treatment Recorded

12 (70.6)

Treatment

The records indicate that the majority (70.6%) of the patients did not have prescribed treatments following diagnosis (Table 5).



< Prev   Next >
Calender

Fellowships
Pfizer Fellowships

Junior Faculty Grants

Fellowships for Junior Faculty are nationally competitive career development awards @ $65,000 for 2 years, in the areas of health disparities or health literacy/clear health communication.

Application deadline: January 15, 2008.
Get Application

Visiting Professorships

Pfizer also offers visiting professorships in multiple areas (e.g. preventive cardiovascular medicine, diabetes, health literacy and health communications, infectious diseases, etc.)

Application deadline: February 5, 2008.

Application and information.


 
Go to top of page  Home | Membership of IADR | Current Issue | Subscription/Reprints | Editorial Board | Submitting Articles | Our Mission | The Web Links | Contact Us | About Us | Download | Advert in AJOH | News |
African Journal of Oral Health. © 2004-2007 All rights reserved. AJOH.org
Design & Hosting by IdeasNetwork